Assessment and treatment of short stature in pediatric patients with chronic kidney disease

A consensus statement

John D. Mahan, Bradley A. Warady, Paul Fielder, Debbie S. Gipson, Larry Greenbaum, Marisa D. Juarez-Congelosi, Frederick J. Kaskel, Craig B. Langman, Lynn D. Long, Dina Macdonald, Deborah H. Miller, Mark M. Mitsnefes, Valerie M. Panzarino, Ronald (Ron) Rosenfeld, Mouin G. Seikaly, Brian Stabler, Sandra L. Watkins

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

Growth failure is a clinically important issue in children with chronic kidney disease (CKD) and is associated with significant morbidity and mortality. Many factors contribute to impaired growth in these children, including abnormalities in the growth hormone (GH) - insulin-like growth factor-I (IGF-I) axis, malnutrition, acidosis, and renal bone disease. The management of growth failure in children with CKD is complicated by the presence of other disease-related complications requiring medical intervention. Despite evidence of GH efficacy and safety in this population, some practitioners and families have been reluctant to institute GH therapy, citing an unwillingness to comply with daily injections, reimbursement difficulties, or impending renal transplantation. Suboptimal attention to growth failure management may be further compounded by a lack of clinical guidelines for the appropriate assessment and treatment of growth failure in these children. This review of growth failure in children with CKD concludes with an algorithm developed by members of the consensus committee, outlining their recommendations for appropriate steps to improve growth and overall health outcomes in children with CKD.

Original languageEnglish (US)
Pages (from-to)917-930
Number of pages14
JournalPediatric Nephrology
Volume21
Issue number7
DOIs
StatePublished - Jul 2006
Externally publishedYes

Fingerprint

Chronic Renal Insufficiency
Consensus
Pediatrics
Growth
Growth Hormone
Therapeutics
Committee Membership
Bone Diseases
Acidosis
Treatment Failure
Insulin-Like Growth Factor I
Malnutrition
Kidney Transplantation
Guidelines
Morbidity
Kidney
Safety
Injections
Mortality
Health

Keywords

  • Chronic kidney disease
  • Chronic renal insufficiency
  • Dialysis
  • Growth failure
  • Growth hormone
  • Renal transplant

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health

Cite this

Mahan, J. D., Warady, B. A., Fielder, P., Gipson, D. S., Greenbaum, L., Juarez-Congelosi, M. D., ... Watkins, S. L. (2006). Assessment and treatment of short stature in pediatric patients with chronic kidney disease: A consensus statement. Pediatric Nephrology, 21(7), 917-930. https://doi.org/10.1007/s00467-006-0020-y

Assessment and treatment of short stature in pediatric patients with chronic kidney disease : A consensus statement. / Mahan, John D.; Warady, Bradley A.; Fielder, Paul; Gipson, Debbie S.; Greenbaum, Larry; Juarez-Congelosi, Marisa D.; Kaskel, Frederick J.; Langman, Craig B.; Long, Lynn D.; Macdonald, Dina; Miller, Deborah H.; Mitsnefes, Mark M.; Panzarino, Valerie M.; Rosenfeld, Ronald (Ron); Seikaly, Mouin G.; Stabler, Brian; Watkins, Sandra L.

In: Pediatric Nephrology, Vol. 21, No. 7, 07.2006, p. 917-930.

Research output: Contribution to journalArticle

Mahan, JD, Warady, BA, Fielder, P, Gipson, DS, Greenbaum, L, Juarez-Congelosi, MD, Kaskel, FJ, Langman, CB, Long, LD, Macdonald, D, Miller, DH, Mitsnefes, MM, Panzarino, VM, Rosenfeld, RR, Seikaly, MG, Stabler, B & Watkins, SL 2006, 'Assessment and treatment of short stature in pediatric patients with chronic kidney disease: A consensus statement', Pediatric Nephrology, vol. 21, no. 7, pp. 917-930. https://doi.org/10.1007/s00467-006-0020-y
Mahan, John D. ; Warady, Bradley A. ; Fielder, Paul ; Gipson, Debbie S. ; Greenbaum, Larry ; Juarez-Congelosi, Marisa D. ; Kaskel, Frederick J. ; Langman, Craig B. ; Long, Lynn D. ; Macdonald, Dina ; Miller, Deborah H. ; Mitsnefes, Mark M. ; Panzarino, Valerie M. ; Rosenfeld, Ronald (Ron) ; Seikaly, Mouin G. ; Stabler, Brian ; Watkins, Sandra L. / Assessment and treatment of short stature in pediatric patients with chronic kidney disease : A consensus statement. In: Pediatric Nephrology. 2006 ; Vol. 21, No. 7. pp. 917-930.
@article{1db82febc92b45668c7749bf83421a82,
title = "Assessment and treatment of short stature in pediatric patients with chronic kidney disease: A consensus statement",
abstract = "Growth failure is a clinically important issue in children with chronic kidney disease (CKD) and is associated with significant morbidity and mortality. Many factors contribute to impaired growth in these children, including abnormalities in the growth hormone (GH) - insulin-like growth factor-I (IGF-I) axis, malnutrition, acidosis, and renal bone disease. The management of growth failure in children with CKD is complicated by the presence of other disease-related complications requiring medical intervention. Despite evidence of GH efficacy and safety in this population, some practitioners and families have been reluctant to institute GH therapy, citing an unwillingness to comply with daily injections, reimbursement difficulties, or impending renal transplantation. Suboptimal attention to growth failure management may be further compounded by a lack of clinical guidelines for the appropriate assessment and treatment of growth failure in these children. This review of growth failure in children with CKD concludes with an algorithm developed by members of the consensus committee, outlining their recommendations for appropriate steps to improve growth and overall health outcomes in children with CKD.",
keywords = "Chronic kidney disease, Chronic renal insufficiency, Dialysis, Growth failure, Growth hormone, Renal transplant",
author = "Mahan, {John D.} and Warady, {Bradley A.} and Paul Fielder and Gipson, {Debbie S.} and Larry Greenbaum and Juarez-Congelosi, {Marisa D.} and Kaskel, {Frederick J.} and Langman, {Craig B.} and Long, {Lynn D.} and Dina Macdonald and Miller, {Deborah H.} and Mitsnefes, {Mark M.} and Panzarino, {Valerie M.} and Rosenfeld, {Ronald (Ron)} and Seikaly, {Mouin G.} and Brian Stabler and Watkins, {Sandra L.}",
year = "2006",
month = "7",
doi = "10.1007/s00467-006-0020-y",
language = "English (US)",
volume = "21",
pages = "917--930",
journal = "Pediatric Nephrology",
issn = "0931-041X",
publisher = "Springer Verlag",
number = "7",

}

TY - JOUR

T1 - Assessment and treatment of short stature in pediatric patients with chronic kidney disease

T2 - A consensus statement

AU - Mahan, John D.

AU - Warady, Bradley A.

AU - Fielder, Paul

AU - Gipson, Debbie S.

AU - Greenbaum, Larry

AU - Juarez-Congelosi, Marisa D.

AU - Kaskel, Frederick J.

AU - Langman, Craig B.

AU - Long, Lynn D.

AU - Macdonald, Dina

AU - Miller, Deborah H.

AU - Mitsnefes, Mark M.

AU - Panzarino, Valerie M.

AU - Rosenfeld, Ronald (Ron)

AU - Seikaly, Mouin G.

AU - Stabler, Brian

AU - Watkins, Sandra L.

PY - 2006/7

Y1 - 2006/7

N2 - Growth failure is a clinically important issue in children with chronic kidney disease (CKD) and is associated with significant morbidity and mortality. Many factors contribute to impaired growth in these children, including abnormalities in the growth hormone (GH) - insulin-like growth factor-I (IGF-I) axis, malnutrition, acidosis, and renal bone disease. The management of growth failure in children with CKD is complicated by the presence of other disease-related complications requiring medical intervention. Despite evidence of GH efficacy and safety in this population, some practitioners and families have been reluctant to institute GH therapy, citing an unwillingness to comply with daily injections, reimbursement difficulties, or impending renal transplantation. Suboptimal attention to growth failure management may be further compounded by a lack of clinical guidelines for the appropriate assessment and treatment of growth failure in these children. This review of growth failure in children with CKD concludes with an algorithm developed by members of the consensus committee, outlining their recommendations for appropriate steps to improve growth and overall health outcomes in children with CKD.

AB - Growth failure is a clinically important issue in children with chronic kidney disease (CKD) and is associated with significant morbidity and mortality. Many factors contribute to impaired growth in these children, including abnormalities in the growth hormone (GH) - insulin-like growth factor-I (IGF-I) axis, malnutrition, acidosis, and renal bone disease. The management of growth failure in children with CKD is complicated by the presence of other disease-related complications requiring medical intervention. Despite evidence of GH efficacy and safety in this population, some practitioners and families have been reluctant to institute GH therapy, citing an unwillingness to comply with daily injections, reimbursement difficulties, or impending renal transplantation. Suboptimal attention to growth failure management may be further compounded by a lack of clinical guidelines for the appropriate assessment and treatment of growth failure in these children. This review of growth failure in children with CKD concludes with an algorithm developed by members of the consensus committee, outlining their recommendations for appropriate steps to improve growth and overall health outcomes in children with CKD.

KW - Chronic kidney disease

KW - Chronic renal insufficiency

KW - Dialysis

KW - Growth failure

KW - Growth hormone

KW - Renal transplant

UR - http://www.scopus.com/inward/record.url?scp=33745107468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745107468&partnerID=8YFLogxK

U2 - 10.1007/s00467-006-0020-y

DO - 10.1007/s00467-006-0020-y

M3 - Article

VL - 21

SP - 917

EP - 930

JO - Pediatric Nephrology

JF - Pediatric Nephrology

SN - 0931-041X

IS - 7

ER -